BR100 Increased By (1.82%)
BR30 Increased By (1.76%)
KSE100 Increased By (2.08%)
KSE30 Increased By (2.29%)
BECO 5.39 No Change ▼ 0.00 (0%)
BML 57.46 Increased By ▲ 0.98 (1.74%)
BOP 36.31 Increased By ▲ 1.22 (3.48%)
CNERGY 8.21 Increased By ▲ 0.04 (0.49%)
DCL 11.83 Increased By ▲ 0.39 (3.41%)
FCCL 59.28 Increased By ▲ 1.73 (3.01%)
FCSC 5.01 Increased By ▲ 0.01 (0.2%)
FFL 17.85 Decreased By ▼ -0.03 (-0.17%)
FNEL 1.26 Increased By ▲ 0.01 (0.8%)
HUMNL 11.50 Increased By ▲ 0.33 (2.95%)
KEL 8.33 Decreased By ▼ -0.21 (-2.46%)
KOSM 6.63 Decreased By ▼ -0.10 (-1.49%)
MLCF 107.43 Increased By ▲ 0.52 (0.49%)
NBP 205.01 Increased By ▲ 6.51 (3.28%)
PACE 11.10 Increased By ▲ 0.03 (0.27%)
PAEL 45.42 Decreased By ▼ -0.03 (-0.07%)
PIAHCLA 31.76 Increased By ▲ 0.33 (1.05%)
PIBTL 18.85 Decreased By ▼ -0.23 (-1.21%)
PPL 243.74 Increased By ▲ 1.12 (0.46%)
PRL 36.24 Increased By ▲ 0.57 (1.6%)
PTC 72.07 Increased By ▲ 6.55 (10%)
SEARL 94.58 Increased By ▲ 0.04 (0.04%)
SSGC 31.85 Decreased By ▼ -0.23 (-0.72%)
TELE 9.02 Increased By ▲ 0.15 (1.69%)
THCCL 68.47 Increased By ▲ 2.81 (4.28%)
TPLP 10.72 Decreased By ▼ -0.01 (-0.09%)
TREET 25.89 Increased By ▲ 0.78 (3.11%)
TRG 64.31 Increased By ▲ 0.64 (1.01%)
WAVES 10.91 Increased By ▲ 0.21 (1.96%)
WTL 1.29 Increased By ▲ 0.04 (3.2%)
Business & Finance

Walgreens forecasts 2021 profit growth after Q4 earnings beat

  • The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.
Published October 15, 2020 Updated October 15, 2020 04:49pm
By

Drugstore chain Walgreens Boots Alliance Inc said on Thursday it expects profit to grow in single digits in 2021, after posting a better-than-expected fourth-quarter profit, helped by higher sales at US pharmacies.

Shares of the largest US drugstore chain rose 2.8pc to $36.93.

The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.

Last quarter, the company suffered a significant decline in footfall in its UK-based retail pharmacies, and resorted to store closures, job cuts and suspension of share repurchases.

Same-store sales at the company's retail pharmacy division in the United States rose 3.6pc from a year earlier.

Excluding items, Walgreens earned $1.02 per share, beating analysts' expectations of 96 cents per share.

Comments

Comments are closed for this article.